Tianjin Zhongrui Pharmaceutical Co., Ltd

Strontium Ranelate

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  Distrontium renelate;5-[Bis(carboxymethyl)amino]-2-carboxy-4-cyano-3-thiopheneacetic acid strontium salt;STRONCIUM RANELATE;5-[bis(carboxymethyl)amino]-3-(carboxymethyl)-4-cyanothiophene-2-carboxylic acid;strontium 5-[bis(carboxylatomethyl)amino]-3-(carboxylatomethyl)-4-cyanothiophene-2-carboxylate hydrate (2:1:7);Ranelate Strontium;5-[Bis(carboxymethyl)amino]-2-carboxy-4-cyano-3-thiopheneacetic acid strontium salt (1:2);

• CAS NO :

  135459-87-9

• EC NO :

• Molecular Formula :

  C₁₂H₂₀N₂O₁₅SSr₂

• Molecular Weight :

  639.5966

• Main Specifications :

• InChI :

  InChI=1/C12H10N2O8S.7H2O.2Sr/c13-2-6-5(1-7(15)16)10(12(21)22)23-11(6)14(3-8(17)18)4-9(19)20;;;;;;;;;/h1,3-4H2,(H,15,16)(H,17,18)(H,19,20)(H,21,22);7*1H2;;/q;;;;;;;;2*+2/p-4

• Packing :

  1kg/bag

• Product description :

  Molecular Formula ：C12H20N2O15SSr2 Molecular Weight：639.5966 Physical Character:Off-white to yellowish crystalline powder Executive standard：Draft Specification of Strontium Ranelate for CFDA Submission pH 6.5～8.5 Related Substances Impurity Ａ≤0.5% Single Impurity≤0.05% Total Impurities≤1.0% Strontium Ranelate Ethyl Ester ≤0.2% Residual Solvents Acetone：≤0.05% Ethanol：≤0.05% Loss on Drying 18.0% ～22.0% Heavy Metals ≤0.002% Assay (Calculated on dried basis) 98.0% ～102.0% Strontium (Calculated on dried basis) 30.7～37.5%

• Uses :

  Mainly used for the treatment and prevention of osteoporosis in postmenopausal women, significantly reduce the risk of vertebral fractures and hip fractures.

• Molecular Structure :